ImmunityBio (IBRX) Insider Trading & Ownership $3.36 +0.58 (+20.86%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$3.38 +0.02 (+0.45%) As of 03/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ImmunityBio (NASDAQ:IBRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage83.40%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$268,516.25Number OfInsiders Selling(Last 3 Years)0 Get IBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunityBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IBRX Insider Buying and Selling by Quarter Remove Ads ImmunityBio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/5/2023Michael D BlaszykDirectorBuy71,915$2.75$197,766.25 6/2/2023John Owen BrennanDirectorBuy25,000$2.83$70,750.00 (Data available from 1/1/2013 forward) IBRX Insider Trading Activity - Frequently Asked Questions Who is on ImmunityBio's Insider Roster? The list of insiders at ImmunityBio includes John Owen Brennan, and Michael D Blaszyk. Learn more on insiders at IBRX. What percentage of ImmunityBio stock is owned by insiders? 83.40% of ImmunityBio stock is owned by insiders. Learn more on IBRX's insider holdings. Which ImmunityBio insiders have been buying company stock? The following insiders have purchased IBRX shares in the last 24 months: John Owen Brennan ($70,750.00), and Michael D Blaszyk ($197,766.25). How much insider buying is happening at ImmunityBio? Insiders have purchased a total of 96,915 IBRX shares in the last 24 months for a total of $268,516.25 bought. ImmunityBio Key ExecutivesDr. Patrick Soon-Shiong F.A.C.S. (Age 71)FRCS (C), M.Sc., Executive Chairman of the Board and Global Chief Scientific & Medical Officer Compensation: $865.34kMr. Richard Gerald Adcock (Age 55)President, CEO & Director Compensation: $1.16MMr. David C. Sachs (Age 46)Chief Financial Officer Compensation: $824.62kDr. Barry J. Simon M.D. (Age 59)Chief Corporate Affairs Officer & Director Dr. Leonard S. Sender M.D.Chief Operating OfficerMs. Regan J. Lauer (Age 54)Chief Accounting Officer Dr. Enrique Diloné Ph.D. (Age 57)RAC, Chief Technology Officer Mr. Jason R. Liljestrom (Age 41)General Counsel & Corporate Secretary Ms. Sarah SingletonChief Communications Officer & Head of Patient AdvocacyDr. Sandeep K. Reddy M.D.Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ROIV Insider Trades SRPT Insider Trades RVMD Insider Trades BBIO Insider Trades LNTH Insider Trades TGTX Insider Trades AXSM Insider Trades BPMC Insider Trades CYTK Insider Trades NUVL Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:IBRX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunityBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunityBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
